Capricor Therapeutics, Inc. Common Stock (NASDAQ: CAPR) last traded at $6.73, down 2.25% on the session. The quote above updates while this page is open; the figures below are drawn from Capricor Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Capricor Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CAPR. Its market capitalisation is $390.98 million.
Valuation measures for Capricor Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $390.98M |
|---|---|
| Enterprise value | $492.57M |
| Price / book | 1.59 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Capricor Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$129.42M |
|---|
| EPS (TTM) | -$2.45 |
|---|
| Return on equity | -52.56% |
|---|
| Cash | $20.94M |
|---|
Range and volume for CAPR over the past 52 weeks.
| 52-week high | $40.37 |
|---|---|
| 52-week low | $2.96 |
| Volume | 679.0K |
| Average volume | 6.83M |
| Previous close | $6.88 |
Invest a chosen dollar amount in Capricor Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CAPR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.